PERMETHRIN

N/A

Manufactured by Insight Pharmaceuticals LLC

3,377 FDA adverse event reports analyzed

Last updated: 2026-04-15

About PERMETHRIN

PERMETHRIN is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Insight Pharmaceuticals LLC. The most commonly reported adverse reactions for PERMETHRIN include DRUG INEFFECTIVE, PRURITUS, OFF LABEL USE, PAIN, RASH. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for PERMETHRIN.

Top Adverse Reactions

DRUG INEFFECTIVE347 reports
PRURITUS139 reports
OFF LABEL USE110 reports
PAIN92 reports
RASH78 reports
HEADACHE75 reports
NAUSEA74 reports
DRY SKIN71 reports
ALOPECIA69 reports
ANXIETY69 reports
CHRONIC KIDNEY DISEASE67 reports
DIARRHOEA54 reports
FATIGUE53 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION51 reports
PRODUCT USE IN UNAPPROVED INDICATION50 reports
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION49 reports
DYSPNOEA48 reports
EMOTIONAL DISTRESS48 reports
ERYTHEMA48 reports
RENAL FAILURE45 reports
DIZZINESS43 reports
VOMITING43 reports
ANHEDONIA39 reports
PSORIASIS38 reports
CONDITION AGGRAVATED37 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS37 reports
ACUTE KIDNEY INJURY36 reports
BURNING SENSATION35 reports
HYPERSENSITIVITY35 reports
ACARODERMATITIS33 reports
PARAESTHESIA33 reports
SKIN BURNING SENSATION31 reports
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION30 reports
FEELING ABNORMAL29 reports
MALAISE29 reports
DEATH28 reports
PAIN IN EXTREMITY28 reports
PSORIATIC ARTHROPATHY28 reports
APPLICATION SITE PAIN26 reports
BACK PAIN26 reports
DEPRESSION25 reports
SKIN IRRITATION25 reports
ASTHENIA24 reports
GASTROINTESTINAL DISORDER24 reports
URTICARIA24 reports
ECONOMIC PROBLEM23 reports
EYE IRRITATION23 reports
HIDRADENITIS23 reports
OVERDOSE23 reports
VISION BLURRED23 reports
PYREXIA22 reports
ABDOMINAL DISCOMFORT21 reports
APPLICATION SITE PRURITUS21 reports
ARTHRALGIA21 reports
DRUG EXPOSURE DURING PREGNANCY21 reports
INCORRECT PRODUCT ADMINISTRATION DURATION21 reports
SKIN DISORDER21 reports
SKIN EXFOLIATION21 reports
BONE DENSITY DECREASED20 reports
URINARY TRACT INFECTION20 reports
ACCIDENTAL EXPOSURE TO PRODUCT19 reports
CELLULITIS19 reports
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE19 reports
TREATMENT FAILURE19 reports
ABDOMINAL PAIN UPPER18 reports
ANAL HAEMORRHAGE18 reports
HYPERTENSION18 reports
HYPOAESTHESIA18 reports
INCORRECT DRUG ADMINISTRATION DURATION18 reports
INSOMNIA18 reports
SKIN HAEMORRHAGE18 reports
SUICIDAL IDEATION18 reports
FALL17 reports
TREMOR17 reports
WEIGHT INCREASED17 reports
ABDOMINAL PAIN16 reports
GAIT DISTURBANCE16 reports
HAIR TEXTURE ABNORMAL16 reports
MYALGIA16 reports
SCRATCH16 reports
ARTHRITIS15 reports
COUGH15 reports
INFECTION15 reports
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES15 reports
NO ADVERSE EVENT15 reports
CONSTIPATION14 reports
DECREASED APPETITE14 reports
DRUG HYPERSENSITIVITY14 reports
HYPOTENSION14 reports
LICE INFESTATION14 reports
OSTEOPENIA14 reports
SEIZURE14 reports
SKIN INFECTION14 reports
THROMBOSIS14 reports
END STAGE RENAL DISEASE13 reports
JOINT SWELLING13 reports
MOVEMENT DISORDER13 reports
OEDEMA PERIPHERAL13 reports
RASH PRURITIC13 reports
SKIN ULCER13 reports

Report Outcomes

Out of 1,706 classified reports for PERMETHRIN:

Serious 45.7%Non-Serious 54.3%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female975 (67.6%)
Male462 (32.0%)
Unknown5 (0.3%)

Reports by Age

Age 4243 reports
Age 6331 reports
Age 6426 reports
Age 5323 reports
Age 5421 reports
Age 5520 reports
Age 5820 reports
Age 6020 reports
Age 5019 reports
Age 4618 reports
Age 917 reports
Age 4517 reports
Age 5217 reports
Age 4916 reports
Age 5116 reports
Age 6216 reports
Age 7416 reports
Age 715 reports
Age 3815 reports
Age 5715 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with PERMETHRIN?

This profile reflects 3,377 FDA FAERS reports that mention PERMETHRIN. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for PERMETHRIN?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, PRURITUS, OFF LABEL USE, PAIN, RASH, HEADACHE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures PERMETHRIN?

Labeling and FAERS entries often list Insight Pharmaceuticals LLC in connection with PERMETHRIN. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.